ClinicalTrials.gov
ClinicalTrials.gov Menu

Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03104725
Recruitment Status : Suspended (The NINDS PIRC has decided to place 17-N-0076 on administrative hold until discrepancies are resolved.)
First Posted : April 7, 2017
Last Update Posted : January 8, 2018
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Neurological Disorders and Stroke (NINDS) )